Ilaria Portarena

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · PubMed · 2003 · 204 citations

Medicine, Oncology, Pharmacology +16

New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes

Oreste Claudio Buonomo, Emanuele Caredda, Ilaria Portarena et al. · PLoS ONE · 2017 · 106 citations · Full text

Medicine, Oncology, Pathology +17

Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy.

Fiorella Guadagni, Patrizia Ferroni, Raffaele Palmirotta et al. · PubMed · 2007 · 83 citations · Full text

Medicine, Oncology, Pharmacology +17

Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · Blood · 2002 · 82 citations · Full text

Medicine, Hematology, Oncology +16

CRH Inhibits Cell Growth of Human Endometrial Adenocarcinoma Cells via CRH-Receptor 1-Mediated Activation of cAMP-PKA Pathway

Grazia Graziani, Lucio Tentori, Ilaria Portarena et al. · Endocrinology · 2002 · 69 citations · Full text

Medicine, Cell Biology, Pharmacology +13